Jeffrey M. Jonas, President & CEO at Sage Therapeutics, Inc. (SAGE), sold 94,264 shares at $171.01 ($16.5M) on 2019-05-23, disclosed to the SEC on 2019-05-24.
Open-market sale of $16.5M SAGE by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $171.01 | 500 | $86K | 0.5% |
| 2 | $172.20 | 1,619 | $279K | 1.7% |
| 3 | $173.41 | 4,200 | $728K | 4.4% |
| 4 | $174.46 | 31,099 | $5.4M | 32.9% |
| 5 | $175.09 | 14,727 | $2.6M | 15.7% |
| 6 | $176.15 | 1,763 |
| $311K |
| 1.9% |
| 7 | $174.05 | 7,948 | $1.4M | 8.4% |
| 8 | $175.02 | 24,966 | $4.4M | 26.5% |
| 9 | $175.79 | 3,974 | $699K | 4.2% |
| 10 | $176.80 | 2,518 | $445K | 2.7% |
| 11 | $177.76 | 950 | $169K | 1.0% |
| Total | $174.75 avg | 94,264 | $16.5M | 100% |
| Filing → |
| KRTX | SELL | 2023-07-05 | $6.0M | — | Filing → |
| SAGE | SELL | 2023-02-10 | $1.0M | — | Filing → |
| SAGE | BUY | 2019-12-10 | $482K | — | Filing → |